At the time the manuscript was being written, Wang et al. [36] had discovered that acquired resistance to BGJ398 is characterized by EMT and a switch in dependency from FGFR to HER2/HER3 in the FGFR3-dependent bladder cancer cell line RT112. Here, ERBB2 is linked to urinary bladder cancer.